{"id":"W2889978819","doi":"10.1016/j.parkreldis.2018.09.005","title":"Impact of dyskinesia on activities of daily living in Parkinson's disease: Results from pooled phase 3 ADS-5102 clinical trials","year":2018,"lang":"en","type":"article","venue":"Parkinsonism & Related Disorders","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; Parkinsonfonden; Allergan; GE Healthcare; Eisai; Adamas Pharmaceuticals; Ipsen; Prothena; Acorda Therapeutics; Parkinson Study Group; Dystonia Coalition; UCB; Sunovion; Acadia University; Revance; Michael J. Fox Foundation for Parkinson's Research; Boston Scientific Corporation; AbbVie; Teva Pharmaceutical Industries; National Psoriasis Foundation; Pfizer; Biogen; Merz Therapeutics; Medtronic; Tourette Association of America; Roche; US WorldMeds; Shire; Eli Lilly and Company; Sanofi; Abbott Laboratories","keywords":"Dyskinesia; Medicine; Activities of daily living; Rating scale; Physical therapy; Trunk; Placebo; Parkinson's disease; Physical medicine and rehabilitation; Disease; Internal medicine; Psychology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002393273,0.0006421735,0.002070619,0.0006047224,0.0001161758,0.00002875198,0.0002937209,0.0004510814,0.0005145034],"category_scores_gemma":[0.005145317,0.0005224431,0.001247977,0.0006824697,0.0004970568,0.0002073774,0.0000954054,0.000503047,0.00005829522],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001963599,"about_ca_system_score_gemma":0.0006528581,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001127123,"about_ca_topic_score_gemma":0.00009646994,"domain_scores_codex":[0.9935077,0.001405462,0.002550001,0.001098507,0.0007630279,0.0006753289],"domain_scores_gemma":[0.9935911,0.002637716,0.001871315,0.001098465,0.0001467836,0.0006545619],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.09700702,0.03304101,0.3973536,0.0002072714,0.008497477,0.0004294596,0.004856359,0.0002215662,0.005185082,0.000205369,0.002507508,0.4504883],"study_design_scores_gemma":[0.05238733,0.006624969,0.9101566,0.001828343,0.00233227,0.000004160181,0.0005060715,0.003361106,0.001494166,0.001782643,0.01880395,0.0007183852],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922846,0.002118732,0.00007703423,0.0002225604,0.0004950991,0.001225382,0.001187148,0.000107979,0.002281452],"genre_scores_gemma":[0.9965659,0.002253144,0.0002461905,0.00008249332,0.0001775001,0.00006937817,0.0003270096,0.000098214,0.0001801491],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.512803,"threshold_uncertainty_score":0.9997227,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04361479724173072,"score_gpt":0.3871359909914078,"score_spread":0.343521193749677,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}